{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T10:40:14Z","timestamp":1734432014074,"version":"3.30.2"},"reference-count":47,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,5,22]],"date-time":"2008-05-22T00:00:00Z","timestamp":1211414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2008,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>In agreement with a recently published manuscript, this present study demonstrated that CD38<jats:sup>+<\/jats:sup> sub\u2010populations had increased proliferative activity as evidenced by higher Ki\u201067 expression (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b70001). This raised the possibility that the CD38<jats:sup>+<\/jats:sup> fraction is exposed to an increased risk of clonal evolution. However, serial fluorescence <jats:italic>in situ<\/jats:italic> hybridisation analysis of highly purified CD38<jats:sup>+<\/jats:sup> and CD38<jats:sup>\u2212<\/jats:sup> sub\u2010populations from individual patients revealed no distinct cytogenetic lesions or evidence of preferential clonal evolution in the CD38<jats:sup>+<\/jats:sup> fractions when compared with their CD38<jats:sup>\u2212<\/jats:sup> counter\u2010parts (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b713). Furthermore, telomere length analysis revealed that all of the sub\u2010populations had similarly short telomeres (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b731) and comparably low telomerase (<jats:italic>TERT<\/jats:italic>) expression (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b775) and telomerase activity (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b788). Subsequent examination of cell\u2010sorted CD38<jats:sup>+<\/jats:sup> and CD38<jats:sup>\u2212<\/jats:sup> sub\u2010populations from paired peripheral blood and bone marrow samples taken on the same day showed no significant difference in CD38, Ki\u201067, <jats:italic>TERT<\/jats:italic> expression or telomere lengths, indicating that these chronic lymphocytic leukaemia cells were derived from a single pool trafficking between these two compartments. Taken together, our data show that chronic lymphocytic leukaemia cells derived from bimodal patients all have extensive proliferative histories and have undergone a similar number of cell divisions that is mirrored by the episodic expression of CD38.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2008.07236.x","type":"journal-article","created":{"date-parts":[[2008,5,22]],"date-time":"2008-05-22T14:00:09Z","timestamp":1211464809000},"page":"595-605","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Highly purified CD38<sup>+<\/sup> sub\u2010populations show no evidence of preferential clonal evolution despite having increased proliferative activity when compared with CD38<sup>\u2212<\/sup> sub\u2010populations derived from the same chronic lymphocytic leukaemia patient"],"prefix":"10.1111","volume":"142","author":[{"given":"Thet Thet","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saman","family":"Hewamana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tammy","family":"Payne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan","family":"Baird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Fegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Pepper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,5,22]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199709051783"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1084"},{"key":"e_1_2_7_4_1","first-page":"4918","article-title":"Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia","volume":"58","author":"Bechter O.E.","year":"1998","journal-title":"Cancer Research"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1042\/BST0340581"},{"key":"e_1_2_7_7_1","doi-asserted-by":"crossref","first-page":"12a","DOI":"10.1182\/blood.V108.11.27.27","article-title":"In vivo labelling of newly synthesized DNA suggests that the CD38+ fraction is enriched in proliferating cells within a clone of chronic lymphocytic leukaemia B cells","volume":"108","author":"Calissano C.","year":"2006","journal-title":"Blood"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2007.03.007"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2249"},{"key":"e_1_2_7_10_1","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle R.N.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1345"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-04-083832"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.160.1.395"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0989"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-10-3873"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-094029"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1557-9190(11)70400-0"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402339"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403147"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830231005"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1801"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4394"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.3.1023"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/47.3.519"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.1.181"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-3890"},{"key":"e_1_2_7_27_1","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.4049\/jimmunol.157.4.1455","article-title":"Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression","volume":"157","author":"Lund F.E.","year":"1996","journal-title":"Journal of Immunology"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/13.4.397"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-003-3296-0"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI23409"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.08.132"},{"key":"e_1_2_7_32_1","first-page":"217","article-title":"Peripheral bood CD38 expression predicts time to progression in B\u2010cell chronic lymphocytic leukemia after first\u2010line therapy with high\u2010dose chlorambucil","volume":"87","author":"Morabito F.","year":"2002","journal-title":"Haematologica"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.69.4.605"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(04)00048-2"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-108605"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404133"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404587"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403975"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.9492"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(98)00154-4"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1078>3.0.CO;2-C"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh389"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2003.11.009"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gng003"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(99)00238-7"},{"key":"e_1_2_7_46_1","first-page":"464","article-title":"Expression of ki\u201067 and bcl\u20102 in 29 cases of chronic lymphocytic leukemia and their clinical significance","volume":"14","author":"Xu W.","year":"2006","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M107474200"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830240532"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2008.07236.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2008.07236.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T09:29:32Z","timestamp":1734427772000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2008.07236.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,22]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["10.1111\/j.1365-2141.2008.07236.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07236.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"type":"print","value":"0007-1048"},{"type":"electronic","value":"1365-2141"}],"subject":[],"published":{"date-parts":[[2008,5,22]]},"assertion":[{"value":"2008-05-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}